Hosted on MSN2mon
Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefitsSpinocerebellar ataxia (SCA ... a group of disorders caused by proteins with abnormal long polyglutamine (polyQ) tracts. These proteins accumulate within nerve cells, forming aggregates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback